DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy

NCT07024693 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Fuchs Endothelial Corneal Dystrophy
Fuchs

Interventions

DRUG: DT-168

Sponsor

Design Therapeutics, Inc.